Free Trial

Aspira Women's Health (AWH) Competitors

Aspira Women's Health logo
$0.75 -0.02 (-2.77%)
(As of 12/23/2024 05:26 PM ET)

AWH vs. VTVT, MAAQ, OMGA, KZR, XCUR, SNYR, ALRN, ACAB, BIVI, and ESLA

Should you be buying Aspira Women's Health stock or one of its competitors? The main competitors of Aspira Women's Health include vTv Therapeutics (VTVT), Mana Capital Acquisition (MAAQ), Omega Therapeutics (OMGA), Kezar Life Sciences (KZR), Exicure (XCUR), Synergy CHC Corp. (Uplisting) (SNYR), Aileron Therapeutics (ALRN), Atlantic Coastal Acquisition Corp. II (ACAB), BioVie (BIVI), and Estrella Immunopharma (ESLA). These companies are all part of the "pharmaceutical products" industry.

Aspira Women's Health vs.

Aspira Women's Health (NASDAQ:AWH) and vTv Therapeutics (NASDAQ:VTVT) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

In the previous week, Aspira Women's Health had 1 more articles in the media than vTv Therapeutics. MarketBeat recorded 1 mentions for Aspira Women's Health and 0 mentions for vTv Therapeutics. vTv Therapeutics' average media sentiment score of 0.49 beat Aspira Women's Health's score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Aspira Women's Health Neutral
vTv Therapeutics Neutral

vTv Therapeutics has a net margin of 0.00% compared to Aspira Women's Health's net margin of -165.07%. Aspira Women's Health's return on equity of 0.00% beat vTv Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aspira Women's Health-165.07% N/A -267.23%
vTv Therapeutics N/A -184.64%-47.29%

Aspira Women's Health currently has a consensus target price of $4.40, indicating a potential upside of 487.69%. vTv Therapeutics has a consensus target price of $35.00, indicating a potential upside of 152.34%. Given Aspira Women's Health's higher possible upside, equities analysts plainly believe Aspira Women's Health is more favorable than vTv Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aspira Women's Health
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
vTv Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

12.2% of Aspira Women's Health shares are owned by institutional investors. Comparatively, 17.5% of vTv Therapeutics shares are owned by institutional investors. 4.3% of Aspira Women's Health shares are owned by company insiders. Comparatively, 1.3% of vTv Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aspira Women's Health has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Comparatively, vTv Therapeutics has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.

Aspira Women's Health has higher revenue and earnings than vTv Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than Aspira Women's Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aspira Women's Health$8.96M1.39-$16.69M-$1.20-0.62
vTv Therapeutics$1M44.25-$20.25M-$4.53-3.06

vTv Therapeutics received 338 more outperform votes than Aspira Women's Health when rated by MarketBeat users. Likewise, 57.80% of users gave vTv Therapeutics an outperform vote while only 18.67% of users gave Aspira Women's Health an outperform vote.

CompanyUnderperformOutperform
Aspira Women's HealthOutperform Votes
14
18.67%
Underperform Votes
61
81.33%
vTv TherapeuticsOutperform Votes
352
57.80%
Underperform Votes
257
42.20%

Summary

Aspira Women's Health beats vTv Therapeutics on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AWH vs. The Competition

MetricAspira Women's HealthDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$12.48M$2.43B$5.20B$9.15B
Dividend YieldN/A0.76%5.12%4.30%
P/E Ratio-0.625.5087.1917.11
Price / Sales1.39124.191,163.55122.70
Price / CashN/A15.0543.2337.84
Price / Book-3.263.324.804.78
Net Income-$16.69M$29.98M$120.46M$225.43M
7 Day Performance-0.20%0.23%-0.89%-0.78%
1 Month Performance-0.16%8.46%14.87%1.05%
1 Year Performance-74.09%-19.70%29.57%15.79%

Aspira Women's Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AWH
Aspira Women's Health
1.2398 of 5 stars
$0.75
-2.8%
$4.40
+487.7%
-74.1%$12.48M$8.96M-0.62110
VTVT
vTv Therapeutics
2.021 of 5 stars
$15.30
+1.8%
$35.00
+128.8%
+54.3%$48.81M$2.02M-3.329Gap Down
MAAQ
Mana Capital Acquisition
N/A$5.99
-23.2%
N/A-57.1%$48.67MN/A0.001Gap Up
High Trading Volume
OMGA
Omega Therapeutics
2.0509 of 5 stars
$0.87
-10.2%
$9.20
+957.5%
-67.2%$48.17M$3.09M0.00120Gap Up
KZR
Kezar Life Sciences
3.7408 of 5 stars
$6.57
-2.7%
$40.50
+516.4%
-23.9%$47.94M$7M-0.5060
XCUR
Exicure
0.8796 of 5 stars
$18.35
+6.0%
N/A+3,016.4%$47.89M$28.83M-9.2750
SNYR
Synergy CHC Corp. (Uplisting)
N/A$5.50
+4.4%
N/AN/A$47.87M$26.01M0.0040Positive News
Gap Up
ALRN
Aileron Therapeutics
3.107 of 5 stars
$2.20
-2.7%
$19.00
+763.6%
-40.6%$47.67MN/A-0.729Positive News
ACAB
Atlantic Coastal Acquisition Corp. II
N/A$5.77
-47.1%
N/A-45.5%$47.14MN/A0.004High Trading Volume
BIVI
BioVie
1.1804 of 5 stars
$2.63
-0.4%
$3.00
+14.1%
+64.8%$46.73MN/A-0.2310
ESLA
Estrella Immunopharma
0.158 of 5 stars
$1.29
+8.1%
N/A-6.6%$46.67MN/A-4.50N/A

Related Companies and Tools


This page (NASDAQ:AWH) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners